WellMedr vs bmiMD: Which Is Better for GLP-1 Weight Loss?
WellMedr and bmiMD are both multi-category telehealth platforms offering compounded GLP-1 medications, but they differ significantly in pricing structure and formulary depth. WellMedr advertises semaglutide from $59/mo (12-month plan) while bmiMD starts at $99/mo with brand-name GLP-1 access up to $349/mo.
We may earn a commission through provider links. Matching affiliate offers and editorial priorities affect inclusion and suggested order in commercial guides. Scores are not clinical endorsements. Disclosure · Methodology
bmiMD has a broader formulary than WellMedr, offering both compounded and brand-name GLP-1 medications (Wegovy, Zepbound, Ozempic, Mounjaro). WellMedr focuses primarily on compounded formulations but adds oral GLP-1 options that bmiMD doesn't advertise. For patients who specifically want FDA-approved brand-name drugs, bmiMD is the only choice between these two.
On pricing, WellMedr is cheaper at the entry level ($59 vs $99/mo for compounded semaglutide), but this requires a 12-month commitment: bmiMD's Trustpilot profile (4.5/5 from 747 reviews) is slightly lower than WellMedr's (4.6/5 from 1,963 reviews), though both are in the Excellent range.
WellMedr
Compounded GLP-1 care with semaglutide shown at $49/mo or tirzepatide at $89/mo with 12-month prepayment; $99/$129 month to month. Verified affiliate coverage is weight loss only.
bmiMD
Plan-length-priced compounded semaglutide with optional longevity add-ons and online clinician access.
Side-by-Side Comparison
| Attribute | WellMedr | bmiMD |
|---|---|---|
| Program Fee | Included in monthly plan | Included in observed semaglutide plan price |
| Medication From | From $49 – $129/mo | From $99 – $129/mo |
| Editor Score | 4.7 / 5 | 4.7 / 5 |
| Primary Category | GLP-1 Weight Loss | GLP-1 Weight Loss |
| FDA Brand-Name Access | Compounded only | Wegovy, Zepbound, Ozempic, Mounjaro |
| Compounded Options | 2 compounds | 2 compounds |
| Adjacent Categories | GLP-1 Weight Loss |
The Verdict
WellMedr wins on compounded GLP-1 pricing ($59 vs $99/mo entry) and Trustpilot score. bmiMD wins on formulary breadth — it offers both compounded and brand-name GLP-1 access. Choose WellMedr for the lowest compounded price on a long-term plan; choose bmiMD if you want the option to switch to brand-name Wegovy or Zepbound later.
Frequently Asked Questions
Does bmiMD offer brand-name Wegovy or Zepbound?
Yes. bmiMD offers brand-name GLP-1 medications including Wegovy and Zepbound, typically at $299-$349/mo. WellMedr focuses on compounded formulations only.
Which is better for long-term use?
Both are viable long-term. WellMedr's 12-month plan is designed for extended use at a lower rate. bmiMD offers more flexibility to switch between compounded and brand-name as availability changes.
Which has better clinical oversight?
Both include clinician review and ongoing messaging. bmiMD has a slightly longer track record. WellMedr uses the OpenLoop Health clinical network.
Can I get oral GLP-1 at either?
WellMedr offers oral semaglutide and oral tirzepatide ODT. bmiMD does not currently advertise oral GLP-1 formulations.